Treating more resistant lung cancers goal of $7.6M gift to University of Michigan
ANN ARBOR, MI - A $7.6-million gift to the University of Michigan’s Rogel Cancer Center will further research into lung cancer treatments. The specific cancer is known as ALK-positive, or non-small cell lung cancer, which affects about 100,000 people globally. “We are very impressed with the talented, multidisciplinary team that the Rogel Cancer Center has brought together to take on this problem,” Tam said in a statement. ALK-positive lung cancer has a high risk of spreading to other parts of the body. Merajver is the lead investigator for the ALK-positive lung cancer initiative, and will implement expertise from the fields of thoracic oncology and surgery, genetics, molecular pharmacology, cell biology, pathology and more.
mlive.com